1-s2-0-s0047272710001751-mainDownload
Archive for category: Intellectual Property Rights
Priority setting for orphan drugs: An international comparison
Pharma Live, , Intellectual Property Rights, 01-s2-0-s0168851010002691-mainDownload
The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?
Pharma Live, , Intellectual Property Rights, 01-s2-0-s016885100900325x-mainDownload
Evaluating and improving orphan drug regulations in Europe: A Delphi policy study
Pharma Live, , Intellectual Property Rights, 01-s2-0-s0168851012002461-mainDownload
1-s2-0-s1098301512041290-mainDownload
Why orphan drug coverage reimbursement decision-makingneeds patient and public involvement
Pharma Live, , Intellectual Property Rights, 01-s2-0-s0168851015000123-mainDownload
Vanda gets favorable Markman ruling in Fanapt patent infringement litigation
Pharma Live, , Intellectual Property Rights, 0WashingtonSaturday, September 12, 2015, 17:00 Hrs Vanda Pharmaceuticals Inc. (Vanda), a biopharmaceutical company, announced that a favourable Markman ruling...
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)